Patents Assigned to Gemmus Pharma Inc.
  • EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
    Patent number: 8980944
    Abstract: The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof.
    Type: Grant
    Filed: March 28, 2011
    Date of Patent: March 17, 2015
    Assignee: Gemmus Pharma Inc.
    Inventors: Daryl Faulds, William J. Guilford, Wolfgang Seifert
  • BERAPROST ISOMER AS AN AGENT FOR THE TREATMENT OF VIRAL INFECTION
    Publication number: 20140275237
    Abstract: In various embodiments the use of single isomer of beraprost as a therapeutic for the treatment of viral disease and other pathologies associated with the induction of a cytokine storm, such as influenza A viruses and the SARS-causing coronvirus and mutations thereof is provided.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: Gemmus Pharma Inc.
    Inventors: DARYL H. FAULDS, WILLIAM J. GUILFORD
  • EP2 AND EP4 AGONISTS AS AGENTS FOR THE TREATMENT OF INFLUENZA A VIRAL INFECTION
    Publication number: 20120190739
    Abstract: The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof.
    Type: Application
    Filed: March 28, 2011
    Publication date: July 26, 2012
    Applicant: GEMMUS PHARMA INC.
    Inventors: Daryl Faulds, William J. Guilford, Wolfgang Seifert
  • EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
    Patent number: 8183286
    Abstract: The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: May 22, 2012
    Assignee: Gemmus Pharma Inc.
    Inventors: Daryl Faulds, William J. Guilford, Wolfgang Seifert